Mostrando 7 resultados de: 7
Filtros aplicados
Publisher
Journal of Neural Transmission(2)
Brain Research(1)
Current Pharmaceutical Design(1)
Journal of Personalized Medicine(1)
Life Sciences(1)
Área temáticas
Farmacología y terapéutica(6)
Enfermedades(5)
Fisiología humana(5)
Ginecología, obstetricia, pediatría, geriatría(1)
Microorganismos, hongos y algas(1)
Origen
scopus(7)
Chronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding
ArticleAbstract: Aim: Examine the effects of chronic oral Methylphenidate (MP) treatment on the N-Methyl-D-aspartic aPalabras claves:ADOLESCENCE, methylphenidate, NMDA, ritalinAutores:David Edward Komatsu, Delis F., Hadjiargyrou M., Hamilton J., Jalloh K., Roeder N., Thanos P.K.Fuentes:scopusChronic oral methylphenidate treatment increases microglial activation in rats
ArticleAbstract: Methylphenidate (MP) is a widely prescribed psychostimulant used to treat attention deficit hyperactPalabras claves:Attention Deficit Hyperactivity Disorder, Autoradiography, inflammation, methylphenidate, Microglia, ritalinAutores:Carias E., David Edward Komatsu, Delis F., Eiden R., Hadjiargyrou M., Hamilton J., Quattrin T., Robison L.S., Thanos P.K.Fuentes:scopusChronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats
ArticleAbstract: Previously, we created an 8-h limited-access dual bottle drinking paradigm to deliver methylphenidatPalabras claves:dopamine, methylphenidate, Psychostimulant, Reward deficiency syndrome, reward, addiction, TransporterAutores:Ananth M., David Edward Komatsu, Hadjiargyrou M., Robison L.S., Thanos P.K.Fuentes:scopusChronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is extensively prescribed for attention deficit hyperactivity disorder (ADHD).Palabras claves:Brain Glucose Metabolism, FDG, imaging, methylphenidate, PetAutores:Blum K., David Edward Komatsu, Delis F., Fricke D., Hadjiargyrou M., Hamilton J., Martin C., Richer K., Sajjad M., Thanos P.K., Yao R.Fuentes:scopusBehavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
ReviewAbstract: The majority of animal studies on methylphenidate (MP) use intraperitoneal (IP) injections, subcutanPalabras claves:ADHD, animal model, Behavior, dopamine, methylphenidate, neurochemistry, Psychostimulant, ritalinAutores:Ahmed R., Arnavut E., Badgaiyan R.D., Blum K., Carvalho A., David Edward Komatsu, Hadjiargyrou M., Lee W.X., Senior D., Thanos P.K.Fuentes:scopusAbstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is a psychostimulant chronically prescribed for the treatment of attention defiPalabras claves:Abstinence, addiction, brain function, FDG, Functional connectivity, glucose utilization, methylphenidate, microPET, PetAutores:Arnavut E., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Sajjad M., Thanos P.K., Yao R.Fuentes:scopusAbstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner
ArticleAbstract: Introduction: Methylphenidate (MP) is a widely used psychostimulant prescribed for Attention DeficitPalabras claves:Attention Deficit Hyperactivity Disorder, Cannabinoid receptor 1, Endocannabinoid system, methylphenidate, Psychostimulant, ritalinAutores:Connor C., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Robison L.S., Thanos P.K.Fuentes:scopus